All Therapeutic Areas
🫁
Respiratory
112 drugs in pipeline from 10 companies
112
Drugs in Pipeline
10
Companies
10
Upcoming Catalysts
112
Phase 3 Trials
Upcoming Catalysts
Tomorrow
6d
RSV/hMPV vaccine candidate Dose L Phase 2 Results Expected
RSV/hMPV vaccine candidate Dose L646
2w
2w
2w
Treprostinil Palmitil Inhalation Powder Phase 3 Results Expected
Treprostinil Palmitil Inhalation Powder31
2w
PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days Phase 2 Results Expected
PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days30
Pipeline by Phase
Phase 3
112
Active Companies
Related Conditions
respiratorylungpulmonarycopdasthmaipfcystic fibrosisbronchitispneumoniaardsfibrosissleep apnea